Refractory Extracutaneous Juvenile Xanthogranuloma With Multiple Intracranial Nodular Lesions Successfully Treated With 2-Chlorodeoxyadenosine
- 3 September 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 44 (3) , e823-e825
Abstract
Juvenile xanthogranulomatosis (JXG) is a rare histiocytic disease that is usually limited to the skin, but some JXG cases involve other organs. JXG involving the central nervous system (CNS) is rare and its treatment is inadequate. The optimum treatment for refractory JXG involving the CNS remains unknown. We report here a case of refractory pediatric extracutaneous JXG (extra-JXG) involving the CNS with multiple intracranial masses treated with 2-chlorodeoxyadenosine resulting in achievement of long-term complete remission. 2-Chlorodeoxyadenosine, with favorable CNS penetration in the cerebrospinal fluid, is apparently an effective treatment for extra-JXG and systemic JXG (sJXG) with CNS involvement.Keywords
This publication has 16 references indexed in Scilit:
- Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2‐chlorodeoxyadenosine: case report and review of the literatureBritish Journal of Dermatology, 2016
- Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 studyBlood, 2015
- Severe persistent bone marrow failure following therapy with 2‐chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brainPediatric Blood & Cancer, 2011
- Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in JapanInternational Journal of Hematology, 2010
- Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribinePediatric Blood & Cancer, 2009
- Treatment of juvenile xanthogranulomaPediatric Blood & Cancer, 2008
- Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2‐chlorodeoxyadenosinePediatric Blood & Cancer, 2007
- Central nervous system juvenile xanthogranuloma with malignant transformationPediatric Blood & Cancer, 2007
- Xanthoma disseminatum: a case report and literature reviewBritish Journal of Radiology, 2005
- Successful Treatment of Congenital Systemic Juvenile Xanthogranuloma With Langerhans Cell Histiocytosis???Based ChemotherapyJournal of Pediatric Hematology/Oncology, 2004